Literature DB >> 14594879

C reactive protein for risk stratification in acute coronary syndromes? Verdict: unproven.

S Kennon1, A D Timmis, R Whitbourn, C Knight.   

Abstract

Although C reactive protein is intimately involved with the pathogenic mechanisms that drive acute coronary syndromes, there is no evidence that it is helpful for identifying patient groups who might benefit from particular treatment strategies

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14594879      PMCID: PMC1767932          DOI: 10.1136/heart.89.11.1288

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  22 in total

1.  Inflammation and thrombosis: the clot thickens.

Authors:  P Libby; D I Simon
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

2.  Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

Authors:  B Lindahl; H Toss; A Siegbahn; P Venge; L Wallentin
Journal:  N Engl J Med       Date:  2000-10-19       Impact factor: 91.245

3.  The effect of aspirin on C-reactive protein as a marker of risk in unstable angina.

Authors:  S Kennon; C P Price; P G Mills; K Ranjadayalan; J Cooper; H Clarke; A D Timmis
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

4.  Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients.

Authors:  Christian Mueller; Heinz J Buettner; John M Hodgson; Stephan Marsch; André P Perruchoud; Helmut Roskamm; Franz-Josef Neumann
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

5.  Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction.

Authors:  R J de Winter; R Bholasingh; J G Lijmer; R W Koster; J P Gorgels; Y Schouten; F J Hoek; G T Sanders
Journal:  Cardiovasc Res       Date:  1999-04       Impact factor: 10.787

6.  Independent prognostic value of elevated C-reactive protein in unstable angina.

Authors:  E R Ferreirós; C P Boissonnet; R Pizarro; P F Merletti; G Corrado; A Cagide; O O Bazzino
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

7.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

Authors:  L Wallentin; B Lagerqvist; S Husted; F Kontny; E Ståhle; E Swahn
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

8.  Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

Authors:  Marc S Sabatine; David A Morrow; James A de Lemos; C Michael Gibson; Sabina A Murphy; Nader Rifai; Carolyn McCabe; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
Journal:  Circulation       Date:  2002-04-16       Impact factor: 29.690

9.  Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy.

Authors:  D H Solomon; P H Stone; R J Glynn; D A Ganz; C M Gibson; R Tracy; J Avorn
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

10.  Systemic inflammation in unstable angina is the result of myocardial necrosis.

Authors:  Michael R Cusack; Michael S Marber; Pier D Lambiase; Clifford A Bucknall; Simon R Redwood
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

View more
  2 in total

1.  C-reactive protein in unstable angina: clinical and angiographic correlation.

Authors:  Prashanth Panduranga; Abdulla A Riyami; Kadhim J Sulaiman; Mohammed Mukhaini
Journal:  Heart Asia       Date:  2010-01-01

2.  Diagnostic Utility of Neuregulin for Acute Coronary Syndrome.

Authors:  Maame Yaa A B Yiadom; Jeremy Greenberg; Holly M Smith; Douglas B Sawyer; Dandan Liu; Jahred Carlise; Laura Tortora; Alan B Storrow
Journal:  Dis Markers       Date:  2016-03-24       Impact factor: 3.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.